Develops monoclonal antibody therapies for patients with autoimmune diseases.
| Title |
|---|
| Associate Director, Pharmacovigilance Full Time United States · Remote |
| Director, Clinical Quality Assurance Full Time · 12+ YOE United States · Remote |
| Senior Director, Clinical Development Full Time · 8+ YOE United States · Remote |
| Senior Manager, Centralized Monitoring Full Time · 5+ YOE United States · Remote |
| Senior Clinical Trial Associate Full Time · 5+ YOE United States · Remote |
| Associate Director, Regulatory CMC Full Time · 8+ YOE United States · Remote |
| Senior Accountant Full Time · 5+ YOE United States · Remote |
| Vice President, Corporate and Internal Communications Full Time · 10+ YOE United States · Remote |
| Clinical Development Medical Director - EMEA / UK Full Time · 5+ YOE United Kingdom · Remote |
| Activities | antibody therapy developmentclinical drug testingmonoclonal antibody engineeringautoimmune disease researchsubcutaneous drug delivery |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Dianthus Therapeutics |
| Employees | 96 |
| Type | Public |
| Subsidiaries | Dianthus Therapeutics OpCo, Inc. |
| Tagline | Develops monoclonal antibody therapies for patients with autoimmune diseases. |
| Founded | 2,019 |
| Website | dianthustx.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | DNTH |